Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.

Most of what is called evidence here is one person, one vial, one month. Fatigue was my main issue with tirzepatide too.

Be careful reading one parcel as a rule. Two successes build a false model.

Customs outcomes are not rulings. A parcel passing is not legal advice.

Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.

Customs outcomes are not rulings. A parcel passing is not legal advice.

Careful with attribution. You changed the timing, the dose and the season. That is three variables.

The cheapest option costs more once you price in the failure rate.

Changing prescriber does not reset anything, and people discover that the hard way. Currently on a coincidence myself.

Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.

What do you do about the fee? Do you just pay it?

Customs outcomes are not rulings. A parcel passing is not legal advice.